Fair questions that i expected would come up as part of the discussion.
1. In my opinion, Nathan Buzza should go - he has failed to demonstrate his value
2. As to who should replace him... That's the difficult question and one I don't have an exact answer for atm. I would be looking for someone that has a proven track record in sales / commercialisation in the healthcare industry, global experience and time to be able to devote to furthering ResApp's interest
- Forums
- ASX - By Stock
- RAP
- Board Refresh
Board Refresh, page-3
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 374 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)